Clinical Trials · NCT05096065
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Enteris BioPharma Inc.
- Enrollment
- 16
- Start date
- Mar 2022
- Locations
- 4 sites, United States
- Primary endpoint
- Adequacy of suppression of estradiol (E2) as assessed by the subject incidence of estradiol level below 20 pg/mL